Your browser doesn't support javascript.
loading
Accounting for fractionation and heterogeneous dose distributions in the modelling of osteoradionecrosis in oropharyngeal carcinoma treatment.
Verduijn, Gerda M; Sijtsema, Nienke D; van Norden, Yvette; Heemsbergen, Wilma D; Mast, Hetty; Sewnaik, Aniel; Chin, Denzel; Baker, Sarah; Capala, Marta E; van der Lugt, Aad; van Meerten, Esther; Hoogeman, Mischa S; Petit, Steven F.
Afiliação
  • Verduijn GM; Departments of Radiotherapy, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands. Electronic address: g.verduijn@erasmusmc.nl.
  • Sijtsema ND; Departments of Radiotherapy, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands; Departments of Radiology and Nuclear Medicine, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands.
  • van Norden Y; Departments of Radiotherapy, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands.
  • Heemsbergen WD; Departments of Radiotherapy, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands.
  • Mast H; Departments of Oral and Maxillofacial Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands.
  • Sewnaik A; Departments of Otorhinolaryngology and Head and Neck Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands.
  • Chin D; Departments of Oral and Maxillofacial Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands.
  • Baker S; Departments of Radiotherapy, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands.
  • Capala ME; Departments of Radiotherapy, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands.
  • van der Lugt A; Departments of Radiology and Nuclear Medicine, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands.
  • van Meerten E; Departments of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands.
  • Hoogeman MS; Departments of Radiotherapy, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands.
  • Petit SF; Departments of Radiotherapy, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands.
Radiother Oncol ; 188: 109889, 2023 Nov.
Article em En | MEDLINE | ID: mdl-37659662

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article